Between Bedside and Bench | Published:

Moving ahead an HIV vaccine: To neutralize or not, a key HIV vaccine question

Nature Medicine volume 17, pages 11951197 (2011) | Download Citation

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Nature 458, 636–640 (2009).

  2. 2.

    et al. PLoS Pathog. 7, e1001251 (2011).

  3. 3.

    et al. Lancet 372, 1881–1893 (2008).

  4. 4.

    et al. N. Engl. J. Med. 361, 2209–2220 (2009).

  5. 5.

    et al. Nature 355, 728–730 (1992).

  6. 6.

    et al. Science 329, 811–817 (2010).

  7. 7.

    et al. J. Virol. 83, 7337–7348 (2009).

  8. 8.

    et al. Nature advance online publication 10.1038/nature10373 (17 August 2011).

  9. 9.

    et al. Nature 467, 591–595 (2010).

  10. 10.

    et al. Science 333, 1630–1632 (2011).

  11. 11.

    et al. Nature 449, 101–104 (2007).

  12. 12.

    et al. J. Infect. Dis. 191, 654–665 (2005).

  13. 13.

    et al. Vaccine 29, 2011–2014 (2011).

  14. 14.

    Clin. Vaccine Immunol. 17, 1055–1065 (2010).

Download references

Author information

Affiliations

  1. Thomas J. Hope is in the Department of Cell and Molecular Biology, Northwestern University Medical School, Chicago, Illinois, USA.

    • Thomas J Hope

Authors

  1. Search for Thomas J Hope in:

Competing interests

The author declares no competing financial interests.

Corresponding author

Correspondence to Thomas J Hope.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nm.2528

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing